Skip to content

Preventive Angioplasty in Myocardial Infarction Trial

Preventive Angioplasty in Myocardial Infarction Trial: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN73028481
Enrollment
600
Registered
2009-10-07
Start date
2008-04-14
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease Circulatory System Chronic ischaemic heart disease

Interventions

Six hundred patients with AMI will be allocated at random to receive therapeutic angioplasty alone or therapeutic angioplasty plus preventive angioplasty undertaken as an immediate follow-on procedure

Sponsors

Queen Mary University of London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients (no age limits, either sex) with acute myocardial infarction undergoing a therapeutic angioplasty to the infarct related artery

Exclusion criteria

Exclusion criteria: 1. Cardiogenic shock 2. Coronary artery bypass graft (CABG)

Design outcomes

Secondary

MeasureTime frame
All outcomes will be recorded during the period of follow up and analysed 1 year after the last patient is recruited: 1. Repeat revascularisation 2. Complications of angioplasty 3. Angina score 4. EQ510 5. Economic evaluation

Primary

MeasureTime frame
All outcomes will be recorded during the period of follow up and analysed 1 year after the last patient is recruited: 1. Death 2. Non-fatal MI 3. Refractory angina

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 12, 2026